Jung Won Hwang

  • Associate
  • T. +82-2-3404-7661
  • F. +82-2-3404-7307
  • E. jungwon.hwang@bkl.co.kr

Overview

Jung Won Hwang is mainly active in general affairs related to securities and finance and focuses on capital markets and corporate finance, securitization and structured finance, and project finance. Ms. Hwang has extensively advised on the cases related to the list of domestic and foreign companies with Korea Exchange, issuance of securities in Korea and abroad, and domestic and overseas project finance.

Ms. Hwang studied law at Yonsei University and earned a J.D. degree at Yonsei University Law School.


 

Representative Experience

2016-Present Bae, Kim & Lee LLC

Representative Matters

Advised the following domestic companies on KRX IPO: LG Energy Solution, Ltd., Kakao Pay Corp., Hyundai Heavy Industries Co., Ltd., K Car Co., Ltd., SD Biosensor, Inc., HK inno.N Corp., Hyundai Energy Solutions, HYBE Co., Ltd., SK Biopharmaceuticals Co., Ltd., Samsung Biologics Co., Ltd., Doosan Bobcat Inc., and etc.
Advised foreign companies or their holding companies on KRX IPO: NeoImmuneTech, Inc., Psomagen, Inc., Englewood Lab, Inc., Organic Tea Cosmetics Holdings Co., Ltd., Access Bio, Inc., and etc.
Advised REIT Public Offering and KRX Listing: KB Star REIT, MASTERN PREMIER REIT, Mirae Asset Global REIT, SK REIT, and etc.
Advised the Korean government on the issuance of foreign-exchange stabilization Bonds in USD 500 million and EUR 700 million, and foreign-exchange equalization bonds in USD 625 million
Advised Korea Water Corporation on the issuance of USD 350 million Green Bond and Asia's first water bonds worth USD 300 million
IPO and KRX Listing
Advised the following domestic companies on KRX IPO: LG Energy Solution, Ltd., Kakao Pay Corp., Hyundai Heavy Industries Co., Ltd., K Car Co., Ltd., SD Biosensor, Inc., HK inno.N Corp., Hyundai Energy Solutions, HYBE Co., Ltd., SK Biopharmaceuticals Co., Ltd., Samsung Biologics Co., Ltd., Doosan Bobcat Inc., and etc.
Advised foreign companies or their holding companies on KRX IPO: NeoImmuneTech, Inc., Psomagen, Inc., Englewood Lab, Inc., Organic Tea Cosmetics Holdings Co., Ltd., Access Bio, Inc., and etc.
Advised REIT Public Offering and KRX Listing: KB Star REIT, MASTERN PREMIER REIT, Mirae Asset Global REIT, SK REIT, and etc.
Securities Offering
Advised the Korean government on the issuance of foreign-exchange stabilization Bonds in USD 500 million and EUR 700 million, and foreign-exchange equalization bonds in USD 625 million
Advised Korea Water Corporation on the issuance of USD 350 million Green Bond and Asia's first water bonds worth USD 300 million
Advised LG Display on the issuance of foreign convertible bonds worth USD 687.8 million
Advised NH Bank on the issuance of social bonds worth USD 600 million and foreign-currency bonds worth USD 500 million, and update of Australian Debt Issuance Programme worth A$5 billion
Advised KDB on the issuance of foreign-currency bonds worth USD 1.5 billion
Advised KEXIM on the update of USD 25 billion GMTN Programme
Offshore Alternative Investment
Advised on the investment in senior and subordinated bonds of an Australian coal terminal
Financial Dispute Matters
Advised on and resolved disputes regarding investments through private equity funds, derivative-linked securities, and specified money trust
Project Finance
Advised E-mart on securitization of chain store assets (KRW 1 trillion)
Advised on the acquisition and development of Nam Chuncheon CC
Advised on PF for Nine One Hannam development

Education

2015 Yonsei University Law School (J.D.)
2012 Yonsei University (LL.B.)

Selected Activities

Awards
IFLR Asia-Pacific Awards - Rising Stars (2023)

Qualifications

2016 Korea

Awards and Recognition